PortfoliosLab logo
COLB vs. BMY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between COLB and BMY is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

COLB vs. BMY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Columbia Banking System, Inc. (COLB) and Bristol-Myers Squibb Company (BMY). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

COLB:

0.69

BMY:

0.30

Sortino Ratio

COLB:

1.23

BMY:

0.76

Omega Ratio

COLB:

1.16

BMY:

1.09

Calmar Ratio

COLB:

0.48

BMY:

0.22

Martin Ratio

COLB:

1.98

BMY:

1.34

Ulcer Index

COLB:

13.32%

BMY:

7.97%

Daily Std Dev

COLB:

38.74%

BMY:

30.47%

Max Drawdown

COLB:

-85.93%

BMY:

-70.62%

Current Drawdown

COLB:

-38.93%

BMY:

-36.34%

Fundamentals

Market Cap

COLB:

$5.03B

BMY:

$94.53B

EPS

COLB:

$2.37

BMY:

$2.68

PE Ratio

COLB:

10.10

BMY:

17.33

PEG Ratio

COLB:

2.26

BMY:

2.26

PS Ratio

COLB:

2.75

BMY:

1.98

PB Ratio

COLB:

0.97

BMY:

5.57

Total Revenue (TTM)

COLB:

$2.64B

BMY:

$47.64B

Gross Profit (TTM)

COLB:

$1.95B

BMY:

$31.43B

EBITDA (TTM)

COLB:

$800.05M

BMY:

$16.18B

Returns By Period

In the year-to-date period, COLB achieves a -10.19% return, which is significantly higher than BMY's -16.07% return. Over the past 10 years, COLB has outperformed BMY with an annualized return of 2.98%, while BMY has yielded a comparatively lower -0.51% annualized return.


COLB

YTD

-10.19%

1M

15.55%

6M

-19.50%

1Y

24.90%

5Y*

7.48%

10Y*

2.98%

BMY

YTD

-16.07%

1M

-7.95%

6M

-12.32%

1Y

8.44%

5Y*

-2.31%

10Y*

-0.51%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

COLB vs. BMY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COLB
The Risk-Adjusted Performance Rank of COLB is 7373
Overall Rank
The Sharpe Ratio Rank of COLB is 7777
Sharpe Ratio Rank
The Sortino Ratio Rank of COLB is 7272
Sortino Ratio Rank
The Omega Ratio Rank of COLB is 7070
Omega Ratio Rank
The Calmar Ratio Rank of COLB is 7272
Calmar Ratio Rank
The Martin Ratio Rank of COLB is 7373
Martin Ratio Rank

BMY
The Risk-Adjusted Performance Rank of BMY is 6262
Overall Rank
The Sharpe Ratio Rank of BMY is 6464
Sharpe Ratio Rank
The Sortino Ratio Rank of BMY is 6060
Sortino Ratio Rank
The Omega Ratio Rank of BMY is 5757
Omega Ratio Rank
The Calmar Ratio Rank of BMY is 6262
Calmar Ratio Rank
The Martin Ratio Rank of BMY is 6868
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

COLB vs. BMY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Columbia Banking System, Inc. (COLB) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current COLB Sharpe Ratio is 0.69, which is higher than the BMY Sharpe Ratio of 0.30. The chart below compares the historical Sharpe Ratios of COLB and BMY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

COLB vs. BMY - Dividend Comparison

COLB's dividend yield for the trailing twelve months is around 6.02%, more than BMY's 5.25% yield.


TTM20242023202220212020201920182017201620152014
COLB
Columbia Banking System, Inc.
6.02%5.33%5.96%6.77%6.05%5.49%5.51%3.72%2.03%3.42%4.68%3.40%
BMY
Bristol-Myers Squibb Company
5.25%4.24%4.44%3.00%2.36%3.69%2.55%3.08%2.55%1.95%2.17%2.46%

Drawdowns

COLB vs. BMY - Drawdown Comparison

The maximum COLB drawdown since its inception was -85.93%, which is greater than BMY's maximum drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for COLB and BMY. For additional features, visit the drawdowns tool.


Loading data...

Volatility

COLB vs. BMY - Volatility Comparison

Columbia Banking System, Inc. (COLB) has a higher volatility of 11.20% compared to Bristol-Myers Squibb Company (BMY) at 10.06%. This indicates that COLB's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

COLB vs. BMY - Financials Comparison

This section allows you to compare key financial metrics between Columbia Banking System, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B20212022202320242025
713.62M
11.20B
(COLB) Total Revenue
(BMY) Total Revenue
Values in USD except per share items